Humana — Feb 11, 2026 release
Fiscal 2025 fourth-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0000049071-26-000005
Showing in the filing
Individual Medicare Advantage membership growth
“approximately 25 percent”
Period
FY2026
Measure
Company-defined measure
Source
Prose
All guidance in this release · 7
GAAP EPS for FY2026
“at least $8.89”
GAAP for FY2026
“at least $8.89”
Adjusted EPS for FY2026
“at least $9.00”
Diluted earnings per share (EPS) - Adjusted … for FY2026
“at least $9.00”
Individual Medicare Advantage membership gro… for FY2026
“approximately 25 percent”
Medicaid footprint expansion (Georgia and Te… for FY2027
“expected to launch in 2027”
Diluted earnings per share (EPS) - GAAP for FY2026
“at least $8.89”
Exhibit 99.1 · the passage around this item
… earlier in the release
Box 1438 Louisville, KY 40202 http://www.humana.com FOR MORE INFORMATION CONTACT: Lisa Stoner Humana Investor Relations (502) 580-2652 e-mail: LStamper@humana.com Mark Taylor Humana Corporate Communications (317) 753-0345 e-mail: MTaylor108@humana.com Humana Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Financial Guidance • Reports 4Q25 net loss per share of $6.61 on a GAAP basis, Adjusted net loss per share of $3.96; reports full year (FY) 2025 earnings per share (EPS) of $9.84 on a GAAP basis, $17.14 on an Adjusted basis; quarterly and FY Adjusted results in line with management's expectations • 4Q25 Insurance segment GAAP benefit ratio of 93.1 percent; FY 2025 Insurance segment GAAP benefit ratio of 90.4 percent, slightly better than guidance of 'the top end of the range of 90.1 percent to 90.5 percent' • Introduces FY 2026 GAAP EPS guidance of 'at least $8.89'; 'at least $9.00' on an Adjusted basis; the anticipated year-over-year decline results from the Star Ratings headwind for Bonus Year 2026, net of mitigation • Anticipates FY 2026 individual Medicare Advantage membership growth of 'approximately 25 percent' over 2025; driven by new sales and improved retention from the company's customer-led benefit strategy and changes to its customer service approach • Continued growth in the CenterWell and Medicaid platforms ◦ Growth of 100,600 patients, or over 25 percent, in CenterWell Senior Primary Care during 2025, including approximately 32,000 patients associated with the acquisition of The Villages Health • Expanded Medicaid footprint, which now spans 13 states, including Georgia and Texas which are expected to launch in 2027 • Publishes prepared management remarks to Investor Relations page of www.humana.com ahead of this morning's 8:00 a.m. ET question and answer session to discuss its financial results for the quarter and expectations for future earnings LOUISVILLE, KY (February 11, 2026) – Humana Inc. (NYSE: HUM) today reported consolidated pretax results and net (loss) earnings per share (EPS) for the quarter ended December 31, 2025 (4Q25) versus the quarter ended December 31 31, 2024 (4Q24) and for the year ended December 31, 2025 (FY 2025) versus the year ended December 31, 2024 (FY 2024) as noted in the tables below. 1 Consolidated (loss) income before income taxes and equity in n
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.